Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/08/2007WO2007127502A2 Polymorphic form of { 2-methyl-4- [ 4-methyl-2- ( 4-triflu0r0methylphenyl) thiazol -5- ylmethylthiol phenoxy }-acetic acid
11/08/2007WO2007127479A2 Triaryl substituted imidazole derivatives and taste-inhibiting uses thereof
11/08/2007WO2007127475A2 Pyridazines for demyelinating diseases and neuropathic pain
11/08/2007WO2007127474A2 Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
11/08/2007WO2007127473A2 Poly (ethylene glycol) containing chemically disparate endgroups
11/08/2007WO2007127396A1 Process for the synthesis of (+) and (-) -1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane
11/08/2007WO2007127382A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
11/08/2007WO2007127366A2 Kinase inhibitors and methods of use thereof
11/08/2007WO2007127364A2 Nonwoven textile assembly, method of manufacture, and spirally wound press felt comprised of same
11/08/2007WO2007127333A2 Compositions for the treatment and prevention of eyelid swelling
11/08/2007WO2007127330A2 Sulfoxy compounds for use in disinfectants
11/08/2007WO2007127297A2 Crystalline forms of a dimethylphenyl compound
11/08/2007WO2007127273A2 Methods and compositions for altering cell function
11/08/2007WO2007127263A2 Therapeutic uses of urolithins
11/08/2007WO2007127262A2 Enantiomers of 2'-fluoralkyl-6-nitroquipazine as serotonin transporter positron emission tomography imaging agents and antidepressant therapeutics
11/08/2007WO2007127237A2 Methods of diagnosing and treating migraine
11/08/2007WO2007127218A2 Streptomyces-derived antimicrobial compound and method of using same against antibiotic-resistant bacteria
11/08/2007WO2007127212A2 Anti-viral agents that activate rnase l
11/08/2007WO2007127196A2 DIALKYLPHENYL COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
11/08/2007WO2007127183A1 Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
11/08/2007WO2007127138A1 Triazoloquinazolinone derivatives as inhibitors of checkpoint kinases
11/08/2007WO2007127137A2 Disubstituted aniline compounds
11/08/2007WO2007127136A2 Antibiotic compounds
11/08/2007WO2007127135A2 Antibiotic compounds
11/08/2007WO2007127012A1 Antifungal agents
11/08/2007WO2007126988A2 Selective androgen receptor modulators and methods of use thereof
11/08/2007WO2007126971A2 Method and composition for treating osteonecrosis and/or avascular necrosis
11/08/2007WO2007126964A2 Kinase inhibitors
11/08/2007WO2007126959A2 Methods and compositions for inducing an immune response to hiv and models for testing
11/08/2007WO2007126935A2 Diazepan orexin receptor antagonists
11/08/2007WO2007126934A2 Amidoethylthioether orexin receptor antagonists
11/08/2007WO2007126924A1 Method for stimulating proteoglycan synthesis in cells
11/08/2007WO2007126913A1 Methods for prevention or treatment of viral disease
11/08/2007WO2007126901A2 Apparatus and method for predicting disease
11/08/2007WO2007126900A2 Antifungal agents
11/08/2007WO2007126898A2 Use of ladostigil for the treatment of schizophrenia
11/08/2007WO2007126886A1 Process for preparing memantine hydrochloride substantially free of impurities
11/08/2007WO2007126871A1 P38 inhibitors and methods of use thereof
11/08/2007WO2007126865A2 Leukotriene antagonists via nasal drug delivery
11/08/2007WO2007126857A1 Diamidine inhibitors of tdp1
11/08/2007WO2007126841A2 Inhibition of alpha-synuclein toxicity
11/08/2007WO2007126840A2 Production of gossypol co-crystals
11/08/2007WO2007126826A2 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives
11/08/2007WO2007126787A2 Reagents and methods for cancer treatment and prevention
11/08/2007WO2007126777A2 Anti-microbial hand towel with time-delay chromatic transfer indicator and absorbency rate delay
11/08/2007WO2007126775A2 Compositions and methods for making and using acyclic n-halamine-based biocidal polymeric materials and articles
11/08/2007WO2007126771A2 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
11/08/2007WO2007126765A2 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
11/08/2007WO2007126745A2 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/08/2007WO2007126415A2 Novel compositions and methods for promoting, inhibiting, and detecting protein entry into cells
11/08/2007WO2007126362A1 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's disease and/or schizophrenia
11/08/2007WO2007126358A1 Diphenylazetidinone derivates possessing cholesterol absor tion inhibitor activit.
11/08/2007WO2007126293A1 Use of (-)-catechin for enhancing the expression of adiponectin
11/08/2007WO2007126136A2 Mask- tasting solid preparation of pioglitazone
11/08/2007WO2007126135A1 Pharmaceutical composition of angiotensin ii antagonists with pioglitazone hcl
11/08/2007WO2007126128A1 Dihydropyrazolopyrimidinone derivative
11/08/2007WO2007126126A1 Novel aminopyridine derivative having aurora-a-selective inhibitory activity
11/08/2007WO2007126122A1 Dihydropyrazolopyrimidinone derivatives
11/08/2007WO2007126117A1 Phenyl 5-thioglucoside compound
11/08/2007WO2007126110A1 Method of producing polymer micelle having low molecular chemical encapsulated therein
11/08/2007WO2007126086A1 Method for purification of reduced coenzyme q10
11/08/2007WO2007126083A1 Method for stabilization of reduced coenzyme q10
11/08/2007WO2007126063A1 Granulated particle, tablet and method for producing granulated particle
11/08/2007WO2007126060A1 Salt of 1,2-dihydropyridine compound
11/08/2007WO2007126043A1 Use as drugs of carboxylic acid derivatives having thiazole rings
11/08/2007WO2007126042A1 2-aminobutanol compound and use thereof for medical purposes
11/08/2007WO2007126041A1 Benzisoxazole compound
11/08/2007WO2007126039A1 Coated macrolide antibiotic preparation
11/08/2007WO2007126020A1 Compound having activity of blocking nmda receptor channel, and pharmaceutical agent using the same
11/08/2007WO2007126001A1 Antitussive or expectorant pharmaceutical composition comprising loxoprofen
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007125915A1 Solid matter containing coenzyme q
11/08/2007WO2007125913A1 Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
11/08/2007WO2007125883A1 Composition for improvement in sleep quality
11/08/2007WO2007125832A1 Singlet oxygen scavenger, anti-skin-aging agent, anti-wrinkle agent, anti-sagging agent, agent for improving moisture content in the skin, skin-whitening agent, melanin formation inhibitor, nitrogen monooxide scavenger and antioxidant, each utilizing helipyrone a
11/08/2007WO2007125823A1 Composition comprising polysaccharide having immunomodulating function as main ingredient
11/08/2007WO2007125731A1 Soft contact lens solution, drug-sustained release soft contact lens prepared by using the solution
11/08/2007WO2007125720A1 Molecular chaperone expression inducer
11/08/2007WO2007125717A1 Agent for amelioration of dysphagia, and pharmaceutical or food composition comprising the same
11/08/2007WO2007125644A1 Fat absorption inhibitor
11/08/2007WO2007125562A2 Method for the preparation and use of an enriched cyanidine-s-o-beta-glucopyranoside extract and derivatives thereof from fruits and vegetables containing said anthocyanin and method for the purification and use of cyanidine-3-o-beta- glucopyranoside and derivatives thereof obtained
11/08/2007WO2007125544A2 Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate
11/08/2007WO2007125542A2 A process for preparation of adapalene
11/08/2007WO2007125501A2 Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness
11/08/2007WO2007125492A2 Acidic composition
11/08/2007WO2007125424A2 Fractional caching
11/08/2007WO2007125414A2 9a-substituted azalides for the tratment of malaria
11/08/2007WO2007125405A2 Substituted 2-amino-fused heterocyclic compounds
11/08/2007WO2007125398A2 : sulfonamide compounds as antagonists of the n-type calcium channel
11/08/2007WO2007125364A1 Piperidines and related compounds for treatment of alzheimer’s disease
11/08/2007WO2007125351A1 Pyrimidine derivatives for the treatment of amyloid-related diseases
11/08/2007WO2007125339A1 Liquid oral compositions
11/08/2007WO2007125330A1 Imidazo[4, 5-b]pyridin-2-one and oxazolo[4, 5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
11/08/2007WO2007125325A1 Pharmaceutical compounds
11/08/2007WO2007125321A2 Purine and deazapurine derivatives as pharmaceutical compounds
11/08/2007WO2007125320A1 Pharmaceutical compounds
11/08/2007WO2007125318A1 Non-aqueous liquid formulation for nasal or buccal administration
11/08/2007WO2007125315A2 Pharmaceutical compounds
11/08/2007WO2007125310A2 Pharmaceutical combinations of pk inhibitors and other active agents
11/08/2007WO2007125295A2 Treatment of hypothyroidism
1 ... 3508 3509 3510 3511 3512 3513 3514 3515 3516 3517 3518 3519 3520 3521 3522 3523 3524 3525 3526 3527 3528 ... 7860